rss
Br J Ophthalmol 83:110-114 doi:10.1136/bjo.83.1.110
  • Original Article
    • Laboratory science

c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma

Table 2

Comparison of c-myc positivity (>50% cells positive on FACS analysis) and Bcl-2 positivity (moderate/strong immunostaining) in uveal melanoma (n=69)

c-myc+ c-myc− Total
Bcl-2+ 34 (49%) 14 (20%) 48 (70%)
Bcl-2− 15 (22%) 6 (9%) 21 (30%)
Total 49 (71%) 20 (29%) 69 (100%)

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.